VanessaFabrizioMDMS(She/Her)

Pediatric Hematology & Oncology • Aurora, CO

Physician

Join to view full profile

Dr. Fabrizio is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Fabrizio's full profile

Already have an account?

Office
13123 E 16th Ave
B115
Aurora, CO 80045

Education & Training

New York Presbyterian Hospital (Cornell Campus)Fellowship, Pediatric Hematology/Oncology, 2017 - 2020
Medical University of South CarolinaResidency, Pediatrics, 2014 - 2017
Drexel University College of MedicineClass of 2014

Certifications & Licensure

MT State Medical License 2022 - 2026
NM State Medical License 2022 - 2026
CO State Medical License 2021 - 2025
SD State Medical License Active through 2025
NE State Medical License 2024 - 2024
NC State Medical License 2020 - 2022
NY State Medical License 2017 - 2022
SC State Medical License 2014 - 2017
American Board of Pediatrics Pediatric Hematology-Oncology
Join now to see all

Clinical Trials

Xylitol BSI Multisite - Reduction of Bloodstream Infections From Oral Organisms in Pediatric Stem Cell Transplant Start of enrollment: 2023 Apr 04
Recruiting
Phase 2
Roles: Principal Investigator, Contact

Publications & Presentations

PubMed

24 citations
Higher doses of tisagenlecleucel are associated with improved outcomes: a report from the pediatric real-world CAR consortium.
Heather E Stefanski, Anne Eaton, Christina Baggott, Jenna Rossoff, Michael R Verneris
Blood Advances. 2023-02-28
24 citations
Adoptive therapy with CMV-specific cytotoxic T lymphocytes depends on baseline CD4+ immunity to mediate durable responses
Vanessa A Fabrizio, M. Irene Rodriguez-Sanchez, Audrey Mauguen, Parastoo B. Dahi, Ekaterina Doubrovina
Blood Advances. 2021-01-26
80 citations
Disease Burden Affects Outcomes in Pediatric and Young Adult B-Cell Lymphoblastic Leukemia After Commercial Tisagenlecleucel: A Pediatric Real-World Chimeric Antigen R...
Liora M Schultz, Christina Baggott, Snehit Prabhu, Holly L Pacenta, Christine L Phillips
Journal of Clinical Oncology. 2022-03-20

Lectures

Allogeneic CD34-Selected HSCT Following CAR T-Cells Is Associated with Low TRM and Favorable OS in Pediatric/Young Adult Patients with Relapsed/Refractory B-ALL
61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019